sTNFRII-Fc modification protects human UC-MSCs against apoptosis/autophagy induced by TNF-α and enhances their efficacy in alleviating inflammatory arthritis

BACKGROUND: Tumor necrosis factor (TNF)-α inhibitors represented by Etanercept (a fusion protein containing soluble TNF receptor II (sTNFRII) and the Fc segment of human IgG1) play a pivotal role in Rheumatoid arthritis (RA) treatment. However, long-term use increases the risk of infection and tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yingjie, Yang, Xuezhi, Li, Siyu, Zhang, Bingjie, Li, Susu, Wang, Xinwei, Wang, Yueye, Jia, Chengyan, Chang, Yan, Wei, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502322/
https://www.ncbi.nlm.nih.gov/pubmed/34627365
http://dx.doi.org/10.1186/s13287-021-02602-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502322/
https://www.ncbi.nlm.nih.gov/pubmed/34627365
http://dx.doi.org/10.1186/s13287-021-02602-4

Ejemplares similares